274 related articles for article (PubMed ID: 36012706)
1. Augmented Therapeutic Potential of EC-Synthetic Retinoids in Caco-2 Cancer Cells Using an In Vitro Approach.
Abdelaal MR; Ibrahim E; Elnagar MR; Soror SH; Haffez H
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012706
[TBL] [Abstract][Full Text] [Related]
2. Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer Therapy.
Abdelaal MR; Soror SH; Elnagar MR; Haffez H
Molecules; 2021 Jan; 26(2):. PubMed ID: 33477997
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line.
Holmes WF; Soprano DR; Soprano KJ
J Biol Chem; 2002 Nov; 277(47):45408-19. PubMed ID: 12237293
[TBL] [Abstract][Full Text] [Related]
4. All-trans retinoic acid enhances the transport of phase II metabolites of benzo[a]pyrene by inducing the Breast Cancer Resistance Protein expression in Caco-2 cells.
Hessel S; Lampen A
Toxicol Lett; 2010 Aug; 197(2):151-5. PubMed ID: 20562004
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids.
Wu Q; Dawson MI; Zheng Y; Hobbs PD; Agadir A; Jong L; Li Y; Liu R; Lin B; Zhang XK
Mol Cell Biol; 1997 Nov; 17(11):6598-608. PubMed ID: 9343423
[TBL] [Abstract][Full Text] [Related]
7. The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases.
Mologni L; Ponzanelli I; Bresciani F; Sardiello G; Bergamaschi D; Gianní M; Reichert U; Rambaldi A; Terao M; Garattini E
Blood; 1999 Feb; 93(3):1045-61. PubMed ID: 9920855
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma.
Meister B; Fink FM; Hittmair A; Marth C; Widschwendter M
Anticancer Res; 1998; 18(3A):1777-86. PubMed ID: 9673404
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of several retinoid receptor-selective ligands on squamous differentiation and apoptosis in airway epithelial cells.
Boisvieux-Ulrich E; Le Pechon-Vallée C; Million K; Baeza-Squiban A; Houcine O; Guennou C; Reichert U; Marano F
Cell Tissue Res; 2000 Apr; 300(1):67-81. PubMed ID: 10805076
[TBL] [Abstract][Full Text] [Related]
10. Comparing the effect of ATRA, 4-HPR, and CD437 in bladder cancer cells.
Zou C; Zhou J; Qian L; Feugang JM; Liu J; Wang X; Wu S; Ding H; Zou C; Liebert M; Grossman HB
Front Biosci; 2006 Sep; 11():2007-16. PubMed ID: 16720286
[TBL] [Abstract][Full Text] [Related]
11. Application of synthetic photostable retinoids induces novel limb and facial phenotypes during chick embryogenesis in vivo.
Lopez-Real RE; Budge JJ; Marder TB; Whiting A; Hunt PN; Przyborski SA
J Anat; 2014 Apr; 224(4):392-411. PubMed ID: 24303996
[TBL] [Abstract][Full Text] [Related]
12. The RARgamma selective agonist CD437 inhibits gastric cell growth through the mechanism of apoptosis.
Jiang SY; Lin DY; Shyu RY; Reichert U; Yeh MY
Cancer Lett; 1999 Apr; 137(2):217-25. PubMed ID: 10374844
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
[TBL] [Abstract][Full Text] [Related]
14. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line.
Zrieki A; Farinotti R; Buyse M
Pharm Res; 2008 Sep; 25(9):1991-2001. PubMed ID: 18581209
[TBL] [Abstract][Full Text] [Related]
16. Natural retinoids inhibit proliferation and induce apoptosis in pancreatic cancer cells previously reported to be retinoid resistant.
el-Metwally TH; Hussein MR; Pour PM; Kuszynski CA; Adrian TE
Cancer Biol Ther; 2005 Apr; 4(4):474-83. PubMed ID: 15908778
[TBL] [Abstract][Full Text] [Related]
17. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
18. Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids.
Sun SY; Kurie JM; Yue P; Dawson MI; Shroot B; Chandraratna RA; Hong WK; Lotan R
Clin Cancer Res; 1999 Feb; 5(2):431-7. PubMed ID: 10037194
[TBL] [Abstract][Full Text] [Related]
19. The molecular basis of the interactions between synthetic retinoic acid analogues and the retinoic acid receptors.
Haffez H; Chisholm DR; Valentine R; Pohl E; Redfern C; Whiting A
Medchemcomm; 2017 Mar; 8(3):578-592. PubMed ID: 30108774
[TBL] [Abstract][Full Text] [Related]
20. Dual mechanisms of action of the retinoid CD437: nuclear retinoic acid receptor-mediated suppression of squamous differentiation and receptor-independent induction of apoptosis in UMSCC22B human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Chandraratna RA; Tesfaigzi Y; Hong WK; Lotan R
Mol Pharmacol; 2000 Sep; 58(3):508-14. PubMed ID: 10953043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
